152 related articles for article (PubMed ID: 7768941)
1. The transcription factor, Nm23H2, binds to and activates the translocated c-myc allele in Burkitt's lymphoma.
Ji L; Arcinas M; Boxer LM
J Biol Chem; 1995 Jun; 270(22):13392-8. PubMed ID: 7768941
[TBL] [Abstract][Full Text] [Related]
2. NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma.
Ji L; Arcinas M; Boxer LM
Mol Cell Biol; 1994 Dec; 14(12):7967-74. PubMed ID: 7969136
[TBL] [Abstract][Full Text] [Related]
3. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
[TBL] [Abstract][Full Text] [Related]
4. Allele-specific activation of the c-myc gene in an atypical Burkitt's lymphoma carrying the t(2;8) chromosomal translocation 250 kb downstream from c-myc.
Tachibana K; Takayama N; Matsuo K; Kato S; Yamamoto K; Ohyama K; Umezawa A; Takano T
Gene; 1993 Feb; 124(2):231-7. PubMed ID: 8444346
[TBL] [Abstract][Full Text] [Related]
5. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
[TBL] [Abstract][Full Text] [Related]
6. Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma.
Rabbitts TH; Forster A; Hamlyn P; Baer R
Nature; 1984 Jun 14-20; 309(5969):592-7. PubMed ID: 6547209
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside diphosphate kinase enzyme activity of NM23-H2/PuF is not required for its DNA binding and in vitro transcriptional functions.
Postel EH; Ferrone CA
J Biol Chem; 1994 Mar; 269(12):8627-30. PubMed ID: 8132589
[TBL] [Abstract][Full Text] [Related]
8. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
9. A Myc-associated zinc finger protein-related factor binding site is required for the deregulation of c-myc expression by the immunoglobulin heavy chain gene enhancers in Burkitt's lymphoma.
Hu HM; Arcinas M; Boxer LM
J Biol Chem; 2002 Mar; 277(12):9819-24. PubMed ID: 11777933
[TBL] [Abstract][Full Text] [Related]
10. The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles.
Spencer CA; LeStrange RC; Novak U; Hayward WS; Groudine M
Genes Dev; 1990 Jan; 4(1):75-88. PubMed ID: 2307371
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.
Smith-Sørensen B; Hijmans EM; Beijersbergen RL; Bernards R
J Biol Chem; 1996 Mar; 271(10):5513-8. PubMed ID: 8621409
[TBL] [Abstract][Full Text] [Related]
12. Transcription-independent repair of nitrogen mustard-induced N-alkylpurines in the c-myc gene in Burkitt's lymphoma CA46 cells.
Wassermann K; O'Connor PM; Jackman J; May A; Bohr VA
Carcinogenesis; 1994 Sep; 15(9):1779-83. PubMed ID: 7923569
[TBL] [Abstract][Full Text] [Related]
13. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
14. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
15. Expression of P0- and P3-RNA from the normal and translocated c-myc allele in Burkitt's lymphoma cells.
Eick D; Polack A; Kofler E; Lenoir GM; Rickinson AB; Bornkamm GW
Oncogene; 1990 Sep; 5(9):1397-402. PubMed ID: 2216463
[TBL] [Abstract][Full Text] [Related]
16. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element.
Berberich SJ; Postel EH
Oncogene; 1995 Jun; 10(12):2343-7. PubMed ID: 7784082
[TBL] [Abstract][Full Text] [Related]
17. Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis.
Postel EH; Berberich SJ; Flint SJ; Ferrone CA
Science; 1993 Jul; 261(5120):478-80. PubMed ID: 8392752
[TBL] [Abstract][Full Text] [Related]
18. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells.
Polack A; Feederle R; Klobeck G; Hörtnagel K
EMBO J; 1993 Oct; 12(10):3913-20. PubMed ID: 8404859
[TBL] [Abstract][Full Text] [Related]
19. Among 17 inducers of differentiation only sodium butyrate causes a permanent down-regulation of c-myc in Burkitt's lymphoma.
Rottleb C; Bornkamm GW; Polack A
Int J Cancer; 1995 Sep; 62(6):697-702. PubMed ID: 7558417
[TBL] [Abstract][Full Text] [Related]
20. Expression of normal and translocated c-myc alleles in Burkitt's lymphoma cells: evidence for different regulation.
Eick D; Bornkamm GW
EMBO J; 1989 Jul; 8(7):1965-72. PubMed ID: 2551669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]